Sabra Health Care REIT, Inc.
SBRA- Exchange
- Nasdaq
- Industry
- Real Estate Investment Trusts
- SEC CIK
- 0001492298
In the last 90 days, Sabra Health Care REIT, Inc. insiders filed 0 open-market purchases and 1 sale; 466 institutions reported holding it in 13F filings for Q2 2026, worth $5.09B in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Sabra Health Care REIT, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 1 filing
- 1 insider, $4.17M in total
- Insiders trading
- 1
- Net value
- −$4.17M
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Sabra Health Care REIT, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Matros Richard K | Chair, CEO and President | 1,657,686Indirect | Sep 9, 2026 | 8 |
| Smith Darrin | Executive VP, CIO & Secretary | 116,919 | Sep 2, 2026 | 5 |
| Malehorn Jeffrey A. | Director | 117,137 | Sep 2, 2026 | 5 |
| Kono Ann | Director | 68,977 | Sep 2, 2026 | 5 |
| Katzmann Lynne S | Director | 86,912 | Sep 2, 2026 | 5 |
| Foster Michael J | Director | 82,834 | Sep 2, 2026 | 7 |
| Cusack Catherine | Director | 82,847 | Sep 2, 2026 | 5 |
| Barbarosh Craig A. | Director | 54,580 | Sep 2, 2026 | 5 |
| Flores Jessica | Executive VP & CAO | 72,476 | Sep 2, 2026 | 8 |
| Costa Michael Lourenco | Executive VP, CFO & Treasurer | 469,879 | Sep 2, 2026 | 7 |
| Nevo-Hacohen Talya | Executive VP, CIO & Treasurer | 340,355 | Dec 2, 2025 | 1 |
| Porter Clifton J II | Director | 49,548 | Jun 3, 2025 | 0 |
| Andrews Harold W. Jr. | Executive VP, CFO & Secretary | 474,693 | Dec 30, 2021 | 0 |
| Geary Ronald G | Director | 51,367 | Dec 2, 2021 | 0 |
| Lewis Raymond J | Director | 218,820 | Dec 2, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 9, 2026 (view filing)7:03 PM ET | Sep 8 | 1 day | Matros Richard KChair, CEO and President | SSale | −200.0K | $20.83 | −$4.17M | −10.8%1.66M after | 10b5-1 |
| Mar 26, 2026 (view filing) | Mar 25 | 1 day | Flores JessicaExecutive VP & CAO | SSale | −15.2K | $19.86 | −$302.5K | −17.5%71.7K after | |
| May 22, 2025 (view filing) | May 20 | 2 days | Foster Michael JDirector | SSale | −11.0K | $18.22 | −$200.4K | −14.5%64.7K after | |
| Feb 25, 2025 (view filing) | Feb 21-24 | 4 days | Cusack CatherineDirector | PPurchase | +2.50K | $16.13 | +$40.3K | +4.3%60.6K after | 2 lots |
| May 23, 2024 (view filing) | May 22 | 1 day | Cusack CatherineDirector | PPurchase | +7.00K | $14.43 | +$101.0K | +17.8%46.4K after | |
| May 17, 2024 (view filing) | May 14 | 3 daysLate | Foster Michael JDirector | SSale | −10.0K | $14.68 | −$146.8K | −13.5%63.9K after | |
| Sep 5, 2023 (view filing) | Sep 1 | 4 days | Costa Michael LourencoExecutive VP, CFO & Secretary | PPurchase | +1.95K | $12.63 | +$24.6K | +1.1%183.2K after | |
| Mar 2, 2022 (view filing) | Feb 25 | 5 days | Cusack CatherineDirector | PPurchase | +2.00K | $13.24 | +$26.5K | +15.4%15.0K after | Amended |
| Dec 30, 2021 (view filing) | Dec 29 | 1 day | Andrews Harold W. Jr.Executive VP, CFO & Secretary | SSale | −110.0K | $13.55 | −$1.49M | −18.8%474.7K after |